Skip to content
lifestyle.latabloid.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NewAmsterdam Pharma N.V.
NewAmsterdam Pharma to Host Investor Day on August 5, 2026
July 29, 2026
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
July 24, 2026
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
May 22, 2026
←
Previous Page
1
2